Vera Therapeutics, Inc. (VERA) compared with its closest peers (CLYM, CGEM, ALMS, CUE, ALEC). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Climb Bio: named as a competitor in the 10-K.
| Company | Market Cap | P/E |
|---|---|---|
| Climb Bio, Inc. (CLYM) | $817.03M | — |
| Cullinan Therapeutics, Inc. (CGEM) | $1.32B | — |
| Alumis Inc. (ALMS) | $1.17B | — |
| Cue Biopharma, Inc. (CUE) | $208.63M | — |
| Alector, Inc. (ALEC) | $236.48M | — |
| Kymera Therapeutics, Inc. (KYMR) | $9.56B | — |
| Entrada Therapeutics, Inc. (TRDA) | $264.17M | — |
| Oruka Therapeutics, Inc. (ORKA) | $6.12B | — |
| Kyverna Therapeutics, Inc. (KYTX) | $448.98M | — |
| Q32 Bio Inc. (QTTB) | $188.39M | 1.4 |
| Sector P/E (Healthcare) | 19.4 |
| Industry P/E (Pharmaceutical Products) | 15.1 |
VERA overview · VERA earnings · VERA financials · VERA KPIs · VERA documents · VERA ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.